DIFFUSION PHARMACEUTICALS IN (DFFN)
Institutional ownership reported to the SEC as of Q2 2023, across 5 quarters.
10
Reporting holders
$454.9K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | $221.2K | 66,232 | 0.00% | 5q | -9.0%-$21.8K |
| BlackRock Inc. | $109.7K | 32,852 | 0.00% | 5q | HELD |
| GEODE CAPITAL MANAGEMENT, LLC | $56.8K | 17,123 | 0.00% | 5q | HELD |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $55.0K | 16,565 | 0.00% | 5q | HELD |
| Tower Research Capital LLC (TRC) | $8.0K | 2,410 | 0.00% | 5q | -27.4%-$3.0K |
| OSAIC HOLDINGS, INC. | $2.0K | 594 | 0.00% | 5q | -3.3% |
| MORGAN STANLEY | $1.8K | 548 | 0.00% | 5q | HELD |
| UBS Group AG | $200 | 60 | 0.00% | 5q | -87.2%-$1.4K |
| RENAISSANCE TECHNOLOGIES LLC | $135 | 40,309 | 0.00% | 5q | +3.1% |
| WELLS FARGO & COMPANY/MN | $50 | 15 | 0.00% | 5q | +7.1% |
| TimeScale Financial, Inc. | $30 | 9 | 0.00% | 3q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2023 | 10 | $454.9K | 136,408 | 0 | 1 | 4 | 0.0% |
| Q1 2023 | 10 | $662.9K | 159,615 | 1 | 2 | 1 | 0.0% |
| Q4 2022 | 10 | $626.7K | 123,764 | 2 | 1 | 1 | 0.0% |
| Q3 2022 | 10 | $1.0M | 187,399 | 0 | 2 | 2 | 0.0% |
| Q2 2022 | 12 | $1.4M | 207,943 | 12 | 0 | 0 | 0.0% |